Introduction: The Addiction Most People Don’t Take Seriously
Cannabis — weed, marijuana, pot, bud, Mary Jane — is the most widely used illicit drug in Australia. According to the Australian Institute of Health and Welfare (AIHW), approximately one in three Australians aged 14 and over have used cannabis at some point in their lives, and around 11.5% reported using it in the past 12 months in the most recent National Drug Strategy Household Survey.
Yet despite its prevalence, cannabis addiction is one of the most consistently dismissed forms of substance dependence. “You can’t get addicted to weed” remains a commonly held belief — one that delays help-seeking, minimises genuine suffering, and leaves many Australians struggling with a real clinical condition without recognising it as such.
The evidence is unambiguous: Cannabis Use Disorder (CUD) is a diagnosable, clinically significant condition that affects a meaningful proportion of people who use the drug regularly. It responds to treatment. And it causes harm — to mental health, cognitive function, relationships, and daily life — whether or not the person experiencing that harm identifies it as addiction.
This article explains what weed addiction actually is, how to recognise it, what it does to the brain and body over time, and what treatment options are available in Australia.
Is Weed Actually Addictive?
Yes. The scientific consensus is clear, even if public understanding has not kept pace with it.
The National Institute on Drug Abuse (NIDA) estimates that approximately 9% of people who use cannabis will develop dependence — a figure that rises to around 17% among those who begin using in adolescence, and approximately 25–50% among daily users. In a country where cannabis use is as widespread as it is in Australia, these percentages represent a very large number of people.
Cannabis addiction works through the same neurobiological mechanisms as other substance use disorders. The active compound in cannabis — delta-9-tetrahydrocannabinol, or THC — acts on the brain’s endocannabinoid system, flooding the reward circuits with dopamine and producing the characteristic “high.” With repeated use, the brain adapts: it downregulates its own cannabinoid receptors and reduces natural dopamine production in response to the artificial stimulation. The result is tolerance — needing more cannabis to feel the same effect — and, over time, a brain that functions less effectively without it.
The DSM-5 classifies Cannabis Use Disorder using the same 11 criteria applied to all substance use disorders — covering impaired control, social impairment, risky use, and pharmacological criteria including tolerance and withdrawal. Meeting two or more criteria within a 12-month period constitutes a diagnosis, regardless of whether the person identifies as “addicted.”
Importantly, cannabis potency has increased dramatically over recent decades. Research published in Drug and Alcohol Dependence found that average THC concentrations in illicit cannabis products have roughly tripled since the 1990s. Higher-potency products produce faster tolerance development, stronger withdrawal effects, and higher rates of dependence — which means the risk profile of contemporary cannabis use is meaningfully different from the drug’s cultural reputation, which was formed during a period of much lower potency.
Signs of Weed Addiction
Because cannabis addiction tends to develop gradually and does not typically produce the acute, visible disruption associated with alcohol or stimulant dependence, it is often well-established before the person — or those around them — recognises it.
The following signs are consistent with Cannabis Use Disorder:
Increased tolerance — Needing significantly more cannabis to achieve the same effect, or finding that the same amount produces noticeably less of a response than it used to.
Using more than intended — Sitting down to have one cone or one joint and finding that an hour later, far more has been used than planned. The gap between intention and behaviour around use is clinically significant.
Unsuccessful attempts to cut back — Deciding to use less, to take a break, or to stop — and finding that this does not translate into behaviour, despite genuine intention.
Significant time spent using or recovering — Organising the day around when and where cannabis can be used, or spending substantial time in a “foggy” state of cognitive impairment following use.
Craving — A strong, often intrusive urge to use, particularly in situations previously associated with cannabis, or during periods of stress, anxiety, or boredom.
Continued use despite problems — Persisting with cannabis use despite awareness that it is contributing to anxiety, motivational difficulties, relationship problems, poor work or academic performance, or financial strain.
Withdrawal when not using — Experiencing irritability, anxiety, sleep disruption, appetite loss, restlessness, or mood instability when cannabis is not available or when attempting to stop. These are recognised symptoms of cannabis withdrawal.
Giving up other activities — Withdrawing from hobbies, exercise, social relationships, or responsibilities that were previously important, in favour of time spent using.
Using in situations where it is risky — Driving under the influence of cannabis, using at work, or using in ways that create legal or safety risks.
Cannabis Withdrawal: Real and Underrecognised
One of the reasons cannabis addiction is frequently dismissed is the perception that withdrawal does not exist or is trivially mild. This is clinically inaccurate.
Cannabis Withdrawal Syndrome is formally recognised in the DSM-5 and the ICD-11. It typically begins within 24–72 hours of cessation in regular, heavy users and may persist for one to three weeks, with some symptoms — particularly sleep disruption and mood instability — lasting longer.
Common cannabis withdrawal symptoms include:
- Irritability, frustration, and anger — often pronounced and disproportionate
- Anxiety and restlessness
- Depressed mood
- Sleep difficulties, including insomnia and vivid or disturbing dreams
- Decreased appetite and weight loss
- Headaches
- Sweating and chills
- Intense cannabis cravings
Research from the AIHW and Australian treatment data indicates that cannabis withdrawal is one of the most commonly cited reasons for relapse among people who attempt to stop without support. The symptoms, while not medically dangerous in the way alcohol withdrawal can be, are genuinely uncomfortable — and for someone with an underlying anxiety disorder or depression (both of which are highly prevalent among people with CUD), they can be significantly destabilising.
Health Effects of Long-Term Cannabis Use
The health consequences of long-term, heavy cannabis use extend well beyond the immediate effects of intoxication. The evidence base has grown substantially in recent years, and the picture it paints is more concerning than the drug’s reputation typically suggests.
Mental Health
The relationship between cannabis and mental health is one of the most extensively studied in addiction medicine — and among the most clinically significant.
Psychosis and schizophrenia — High-potency cannabis use is associated with a significantly elevated risk of psychotic episodes and, in susceptible individuals, schizophrenia. A major study published in The Lancet Psychiatry found that daily use of high-potency cannabis was associated with a fivefold increase in the odds of psychosis compared to those who had never used. This risk is substantially higher in people with a personal or family history of psychotic disorders.
Anxiety and depression — Cannabis is widely used to manage anxiety and low mood, but the evidence consistently shows that regular use worsens both over time. The temporary anxiolytic effect of THC gives way to heightened baseline anxiety, particularly during withdrawal periods — a cycle that can become self-perpetuating.
Motivational syndrome — Chronic heavy cannabis use is associated with reduced motivation, flattened affect, diminished capacity for pleasure from non-drug activities (anhedonia), and difficulty initiating or sustaining goal-directed behaviour. In younger users, this can have lasting impacts on educational and vocational development.
Cognitive Function
Regular cannabis use — particularly use that began in adolescence or young adulthood — is associated with impairments in memory, attention, processing speed, and executive function. A longitudinal study published in Proceedings of the National Academy of Sciences found that adolescent-onset heavy cannabis users showed significant declines in IQ compared to peers. While some cognitive functions recover with extended abstinence, some deficits — particularly in those who began using early — appear to persist.
Respiratory Health
Smoked cannabis contains many of the same toxins and carcinogens as tobacco smoke. Chronic cannabis smoking is associated with chronic bronchitis, increased respiratory infections, and impaired lung function. The Cancer Council Australia identifies cannabis smoking as a risk factor for lung cancer, with risk compounded by the common practice of mixing cannabis with tobacco.
Cardiovascular Health
Cannabis use acutely increases heart rate and has been associated with elevated risk of myocardial infarction in younger users in the hours following heavy use. This risk is particularly relevant for those with pre-existing cardiovascular conditions.
Cannabis and Young Australians
The AIHW reports that cannabis is most commonly first used in the teenage years, and that the harms associated with cannabis use are disproportionately concentrated in younger people. The adolescent brain — still undergoing significant development until the mid-twenties — is both more sensitive to the rewarding effects of THC and more vulnerable to its long-term consequences.
Australian data from the National Drug Strategy Household Survey shows that cannabis use among young adults aged 18–24 is notably higher than in older age cohorts. For young people already experiencing mental health challenges — a population already at elevated risk — cannabis use can significantly complicate and worsen the clinical picture.
For families concerned about a young person’s cannabis use, Family Drug Support Australia (1300 368 186) provides specialist support and guidance.
Treatment for Weed Addiction in Australia
Cannabis Use Disorder is treatable — and a range of evidence-based options are available in the Australian system.
Psychological Therapies
Cognitive Behavioural Therapy (CBT) is the best-evidenced psychological treatment for cannabis use disorder. It helps people identify triggers, challenge beliefs that maintain use, develop coping strategies, and build a life in which cannabis is no longer the primary source of relief or reward. The Alcohol and Drug Foundation (ADF) identifies CBT as the first-line psychological intervention for CUD.
Motivational Enhancement Therapy (MET) — a structured form of motivational interviewing delivered over a small number of sessions — has a strong evidence base for cannabis use disorder specifically, and is often combined with CBT in what is known as the MET/CBT protocol.
Mindfulness-Based Relapse Prevention (MBRP) combines mindfulness practice with cognitive-behavioural relapse prevention skills. Research supports its effectiveness in reducing cannabis use and relapse rates.
Medication
There is currently no approved pharmacotherapy specifically for cannabis use disorder. However, medications can be used to manage specific withdrawal symptoms — particularly sleep disruption, anxiety, and mood instability — which are common barriers to sustained abstinence. A GP or addiction medicine specialist can advise on appropriate symptomatic support.
Residential Rehabilitation
For individuals with severe or long-standing cannabis dependence, co-occurring mental health conditions, or prior unsuccessful attempts at outpatient treatment, residential rehabilitation provides the most intensive and supported environment for change. The removal from the using environment, combined with intensive daily therapy, addresses both the addiction and the psychological and social factors that maintain it.
HARP’s residential treatment programme supports people with cannabis use disorder alongside the full spectrum of substance presentations, with individualised treatment plans, psychological therapy, and integrated mental health support.
Online and Community Resources
- Cannabis Coach — A free, evidence-based self-help programme developed by the National Cannabis Prevention and Information Centre (NCPIC), now available through the ADF
- SMART Recovery Australia — Peer support meetings available online and in-person nationwide
- National Alcohol and Other Drug Hotline — 1800 250 015 (free, confidential, 24/7)
When to Seek Help
If cannabis is affecting your work, your relationships, your mental health, or your ability to get through a day without using — that is a reason to seek support, regardless of how severe it appears by comparison to other forms of addiction.
Cannabis use disorder is not a lifestyle choice or a character flaw. It is a clinical condition with well-understood mechanisms, clear diagnostic criteria, and effective treatment options. The earlier it is addressed, the more straightforward the recovery process tends to be.
For a broader understanding of how addiction develops and what treatment involves, visit our Complete Guide to Addiction.
Frequently Asked Questions
Can you really get addicted to weed? Yes. Cannabis Use Disorder is a formally recognised clinical diagnosis under both the DSM-5 and ICD-11. Approximately 9% of people who use cannabis develop dependence overall — rising to around 17% of those who start in adolescence and up to 50% of daily users. The risk is real, well-documented, and commonly underestimated.
What does cannabis withdrawal feel like? Cannabis withdrawal typically involves irritability, anxiety, disrupted sleep, vivid dreams, decreased appetite, restlessness, and mood swings. Symptoms generally begin within 24–72 hours of stopping and can persist for one to three weeks. They are not medically dangerous but can be genuinely distressing — and for people with underlying anxiety or depression, they can be significantly destabilising.
How is weed addiction treated? The most evidence-based treatments are psychological — primarily Cognitive Behavioural Therapy (CBT) and Motivational Enhancement Therapy (MET). For more severe or complex presentations, residential rehabilitation provides a structured environment for intensive therapeutic work. There is currently no approved medication specifically for cannabis use disorder, though medications can be used to manage specific withdrawal symptoms.
Is weed addiction covered by Medicare or private health insurance? Treatment for cannabis use disorder may be partially funded through Medicare — a GP can provide a Mental Health Care Plan that subsidises up to 10 psychology sessions per year. Residential rehabilitation is generally covered under the psychiatric inpatient benefit of private health insurance policies, subject to policy terms, waiting periods, and fund agreements. Your GP and the admissions team at a residential programme can assist with navigating funding options.
Sources
- AIHW — National Drug Strategy Household Survey 2022–23
- NIDA — Cannabis (Marijuana) DrugFacts
- DSM-5 — American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (2013)
- The Lancet Psychiatry — Di Forti M et al., “The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe,” The Lancet Psychiatry (2019)
- Drug and Alcohol Dependence — Chandra S et al., “New trends in cannabis potency in the USA and Europe,” Drug and Alcohol Dependence (2019)
- Alcohol and Drug Foundation (ADF) — Cannabis Treatment
- Cancer Council Australia — Cannabis and Cancer Risk
- National Alcohol and Other Drug Hotline — 1800 250 015 (free, confidential, 24/7)
- Family Drug Support Australia — 1300 368 186
This article is reviewed for clinical accuracy and is intended for educational purposes only. It does not constitute medical advice. Please speak with your GP or a qualified AOD specialist for personalised guidance.
